Why the world's most expensive drug might not be all that overpriced

The staff of the Institute for Clinical and Economic Review, or ICER, are known as the nerds of the drug industry: bespectacled killjoys who emerge a few times a year to scold drugmakers for pricing their latest cancer or MS advance far beyond reason.

You are viewing a robot-friendly page.Click hereto reload in standard format.